Hello and welcome,
By taking part in this year's Global Drug Survey, you will be part of the biggest survey of drug
use patterns in the world. Last year over 100,000 took part in GDS2015. Our target this year,
with media partners in 19 countries and with the survey having been translated into 10 languages
is 120,000. That’s a lot of experience, expertise and opinion to share.
The survey is anonymous and confidential
Read more
We ask about your age gender and location to help
us prepare meaningful reports so we can compare patterns of drug use across the world and provide
our media partners with the correct information about local patterns of use. Based on feedback
from GDS2015, this year’s survey is shorter with a focus on the following areas: new drug trends,
the darknet, new forms of cannabis, prescription drug use, the internet and of course alcohol and
tobacco.
By taking part you consent for your information to be used by GDS in the preparation of its reports,
health promotion activities and academic publications. You may withdraw your participation at any
time and your data will not be submitted till the end of the survey.
As always we will ensure that you are the first to see the results through exclusive reports provided
to our media partners who this year span Europe, the USA and Australasia.
Thank once again for taking part this year – we’ll get back to you with the result in May/June 2016
Have a happy and safe 2016
Dr Adam R Winstock
Founder Global Drug Survey
On behalf of the global GDS team
For further information please check our website of contact me at
adam@globaldrugsurvey.com.
Global Drug Survey is an independent drug use data-mapping agency, based in London. This research has
been approved by the King’s College London Psychiatry, Nursing and Midwifery Research Ethics
Subcommittee (PNM/14/15-18).
Select your language to start the survey, it may take a minute or two to load.
Global Drug Survey is an independent drug use data-mapping agency, based in London.
This research has received approval from the South London and Maudsley NHS Trust and Institute of Psychiatry Joint Ethics Committee, London England, and by The Ethics Committee of the Philosophical Faculty of the University of Zurich.
